Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.1 M1.49 M1.64 M10.04 M7.3 M 20.47 M Research & development ————4.57 M — Operating income -1.1 M-1.49 M-1.64 M-17.19 M-11.93 M -32.25 M Non-Operating Income, Total 1.79 M2.09 M3.57 M-7.08 M1.47 M 36.78 K Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 1.79 M2.09 M3.57 M-7.08 M1.47 M 36.78 K Unusual income/expense ————— — Pretax income 690 K601.03 K1.93 M-28 M-10.47 M -35.94 M Equity in earnings ————— — Taxes ———-1.68 M37 K — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 690 K601.03 K1.93 M-24.29 M-10.5 M -32.27 M Discontinued operations ————— — Net income 690 K601.03 K1.93 M-24.29 M-10.5 M -32.27 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 690 K601.03 K1.93 M-31.24 M-10.5 M -39.21 M Basic earnings per share (Basic EPS) 0.040.040.14—-0.1 — Diluted earnings per share (Diluted EPS) 0.040.040.14-0.34-0.1 -0.26 Average basic shares outstanding 28.75 M28.75 M28.75 M71.65 M105.86 M — Diluted shares outstanding 28.75 M28.75 M28.75 M71.65 M105.86 M — EBITDA ————-11.9 M — EBIT -9.41 M943.42 K825.72 K—-11.96 M — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ———25.25 K61 K —